Horizontal Versus Vertical Upper Extremity Function in Bilateral Cerebral Palsy (NCT07367477) | Clinical Trial Compass
By InvitationNot Applicable
Horizontal Versus Vertical Upper Extremity Function in Bilateral Cerebral Palsy
Egypt30 participantsStarted 2025-06-16
Plain-language summary
The goal of this quasi-experimental study is to investigate and compare the effects of horizontal and vertical upper extremity performance on hand skills and trunk control in children with bilateral spastic cerebral palsy; could include any of the following: both gender, age ranged from 5 years to 8 years. The main question it aims to answer \[is/are\]:
There will be no significant difference effect between horizontal and vertical upper extremity performance on hand skills and trunk control in children with bilateral spastic cerebral palsy.
Who can participate
Age range
5 Years – 8 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Children with BSCP, their chronological age will be ranged from 5 years to 8 years.
* Their level of motor function will be I or II according to Gross Motor Function Classification System - Expanded and Revised.
* The degree of spasticity for these children will ranged from grade 1 to 1⁺ according to Modified Ashworth Scale.
* Their level of fine motor function will be I or II according to The Bimanual Fine Motor Function.
* All children's level of segmental trunk control will be level 7 (full trunk control) according to Segmental Assessment of Trunk Control.
* They will be able to follow instructions during evaluation and treatment.
Exclusion Criteria:
* Surgical interference in upper limbs and/or spine that may restrain the child performance during activities.
* Orthopedic problems or fixed deformities in the vertebral column and/or upper extremities.
* Uncontrolled seizures.
* Visual or hearing impairment.
* Receiving special medication affecting muscle and /or mental function.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Fine motor proficiency
Timeframe: Before and after the three months of treatment
2
Change in upper extremity function
Timeframe: Before and after the three months of treatment
3
Change in trunk stability from sitting
Timeframe: Before and after the three months of treatment